Market Overview

Concert Pharma (NASDAQ: CNCE)

10.62 +0.35 (3.41%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2021
Pre-Market
EPS:
REV:




Q4 2020
Pre-Market
EPS:
REV:




Q3 2020
Pre-Market
EPS:
REV:
-0.72
10K



Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-0.93
1.005M
-0.78
10K
-0.70
7K
10.26%
-30%
Q4 2019
Pre-Market
EPS:
REV:
-0.89
13K
-0.79
10K
-0.86
13K
-8.86%
30%
Q3 2019
Pre-Market
EPS:
REV:
-0.74
11K
-0.83
60K
-0.72
10K
13.25%
-83.33%
Q2 2019
Pre-Market
EPS:
REV:
-0.57
2K
-0.89
50K
-0.78
49K
12.36%
-2%
Q1 2019
Pre-Market
EPS:
REV:
-0.19
10.479M
-0.62
5.35M
-0.93
1.005M
-50%
-81.21%
Q4 2018
Pre-Market
EPS:
REV:
-0.26
12K
-0.74
-0.89
13K
20.27%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!